Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
PROK ProKidney
- 0.977
- -0.073-6.99%
Close Mar 10 16:00 ET
124.97MMarket Cap-1.81P/E (TTM)
1.060High0.940Low415.76KVolume1.020Open1.050Pre Close407.55KTurnover0.52%Turnover RatioLossP/E (Static)127.97MShares4.44052wk High-0.13P/B77.74MFloat Cap0.94052wk Low--Dividend TTM79.61MShs Float14.190Historical High--Div YieldTTM11.43%Amplitude0.940Historical Low0.980Avg Price1Lot Size
About ProKidney Company
ProKidney Corp（formerly Social Capital Suvretta Holdings Corp. III） is an advanced biotechnology company founded by innovators. The company was founded on 2015, is a pioneer in the innovative treatment of chronic kidney disease (CKD) through cell therapy.
Company Profile
SymbolPROK
Company NameProKidney
Listing DateJun 30, 2021
Founded2015
CEODr. Bruce Culleton, M.D.
MarketNASDAQ
Employees163
Fiscal Year Ends12-31
Address2000 Frontis Plaza Boulevard,Suite 250
CityWinston-Salem
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27103
Phone1-336-999-7028
Websitehttps://www.prokidney.com/
Company Executives
- Name
- Position
- Salary
- Dr. Bruce Culleton, M.D.
- Chief Executive Officer and Director
- 8.71M
- James Coulston, C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- 2.29M
- Todd C. Girolamo, J.D.,M.B.A.
- Chief Legal Officer
- 2.30M
- Dr. Darin J. Weber, PhD
- Chief Regulatory Officer and Senior Vice President, Global Regulatory, Quality Management and Commercial
- --
- Lucio Tozzi
- Senior Vice President, Global Clinical Operations
- --
- Dr. Ulrich Ernst, PhD
- Executive Vice President, Technical Operations
- --
- Pablo Legorreta
- Chairman of the Board
- 434.10K
- Jennifer A. Fox
- Independent Director
- 749.64K
- William F. Doyle
- Independent Director
- 413.10K
- Jose Ignacio Jimenez Santos
- Independent Director
- 404.60K
- Dr. Brian J.G. Pereira,M.D.
- Independent Director
- 421.10K
- Dr. Uma Sinha, PhD
- Independent Director
- 410.60K
- Dr. Alan M. Lotvin, M.D.
- Independent Director
- 423.60K